Switch to:

Epizyme Inc (EPZM) Ownership Data

Short Interest History (%)

This is the historical short interest of Epizyme Inc, as measured by the Short Percentage Of Float.

Date Short Interest
May 15, 201538.97
April 30, 201533.26
April 15, 201534.53
March 31, 201534.16
March 13, 201536.01
February 27, 201531.56
February 13, 201531.54
January 30, 201531.13
January 15, 201526.81
December 31, 201425.64
December 15, 201428.23
November 28, 201428.23
November 14, 201425.92
October 31, 201429.44
October 15, 201427.85
September 30, 201427.59
September 15, 201421.27
August 29, 201419.75
August 15, 201426.66
July 31, 201426.75
July 15, 201423.47
June 30, 201420.74
June 13, 201421.36
May 30, 201421.76
May 15, 201421.27
April 30, 201423.53
April 15, 201426.15
March 31, 201423.29
March 14, 201421.81
February 28, 201419.26
February 14, 201429.76
January 31, 201427.11
January 15, 201424.42
December 31, 201331.01
December 13, 201332.09
November 29, 201331.26
November 15, 201322.8
October 31, 201316.04
October 15, 201316.36
September 30, 201314.46
September 13, 201313.2
August 30, 201311.65
August 15, 20138.87
July 31, 20138.02
July 15, 20136.44
June 28, 20133.76
June 14, 20133.53

Institutional Ownership History (%)

This the Institutional Ownership History of Epizyme IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
March 31, 201497
February 28, 201495
December 31, 201397
November 30, 201351
October 31, 201351
September 30, 201347
August 31, 201347
July 31, 201346
June 30, 20131

Insider ownership (%)

This is the historical insider ownership of Epizyme Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Jason P. RhodesPresident, CFO and Treasurer138,0000.33%2014-09-22
Mr. Stephen GarbaczPrincipal Accounting Officer13,073less than 0.1%2014-11-03
Mr. Patrick J. Kerins10% Owner651less than 0.1%2014-08-14
Mr. Eric HedrickChief Medical Officer429less than 0.1%2014-10-15
Tai-Ching Peter HoChief Development Officer200less than 0.1%2014-12-02

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
NEW ENTERPRISE ASSOCIATES 11 LP6,446,0892014-02-2819.680.00192,738,061
PRIMECAP Management Company Premium6,023,6052015-03-3114.880.11113,123,000
Fidelity Management and Research Company   Premium Plus5,366,4392015-03-3113.250.01100,782,000
NEA Management Company, LLC   Premium Plus5,149,7402015-03-3112.724.3796,712,000
KLEINER PERKINS CAUFIELD & BYERS X A LP4,115,5552014-02-2812.570.00123,055,094
Fidelity® Select Biotechnology Portfolio3,922,2072015-03-319.690.5373,659,047
Kleiner Perkins Caufield & Byers XIII LLC3,838,1672014-12-3111.150.0072,426,211
Celgene Corp3,674,6402014-02-2811.220.00109,871,736
PrimeCap Odyssey Aggressive Growth Fund3,439,8622015-03-318.500.9564,600,608
BAY Capital Management3,192,0622014-02-289.750.0095,442,654

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK